LCTX
Lineage Cell Therapeutics Inc
1.00$
+8.7%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 14.9% | 2.6% | 15.0% | 1.3% | 11.2% | 9.5% | 29.1% | 17.5% | 13.3% | 30.4% | 38.0% | 42.8% | 52.5% | 14.8% | 56.6% | 75.8% | 29.8% | 68.7% | 38.2% | 28.3% | 44.7% | 21.3% | 3.4% | 4.7% | 7.8% | 5.3% | 5.0% | 3.9% | 13.6% | 20.6% | 18.9% | 3.1% | 1.0% | 5.4% | 2.4% | 1.4% | 0.1% | 1.0% | 10.9% | 17.5% | 3.4% | |
| 85.1% | 97.4% | 85.0% | 98.7% | 88.8% | 90.5% | 70.9% | 82.5% | 86.7% | 69.6% | 62.0% | 57.2% | 47.5% | 85.2% | 43.4% | 24.2% | 70.2% | 31.3% | 61.8% | 71.7% | 55.3% | 78.8% | 96.6% | 95.3% | 92.2% | 94.7% | 95.0% | 96.1% | 86.4% | 79.4% | 81.1% | 96.9% | 99.0% | 94.6% | 97.6% | 98.6% | 99.9% | 99.0% | 89.1% | 82.5% | 96.6% | |
| 1,646.7% | 925.2% | 1,713.5% | 1,645.9% | 1,417.3% | 825.5% | 1,582.7% | 1,049.2% | 1,849.2% | 2,210.5% | 2,771.5% | 2,094.0% | 1,965.9% | 419.0% | 2,011.4% | 2,833.3% | 1,042.7% | 1,570.5% | 1,158.4% | 664.6% | 127.7% | 2,581.0% | 57.1% | 72.5% | 119.8% | 214.3% | 175.4% | 120.1% | 300.2% | 185.5% | 206.9% | 203.7% | 83.9% | 119.4% | 207.3% | 112.3% | 88.9% | 124.7% | 245.4% | 446.6% | 156.8% | |
| 1,172.8% | 704.9% | 1,345.9% | 1,160.9% | 990.7% | 1,021.3% | 1,611.7% | 862.5% | 2,432.6% | 4,112.9% | 4,838.0% | 2,503.2% | 2,124.0% | 541.3% | 2,722.3% | 3,947.5% | 1,060.8% | 2,118.1% | 1,343.0% | 1,028.6% | 241.5% | 460.8% | 161.7% | 115.7% | 147.5% | 227.0% | 198.0% | 131.8% | 324.3% | 205.4% | 346.1% | 309.9% | 116.7% | 153.5% | 323.4% | 164.9% | 113.9% | 73.4% | 294.7% | 488.1% | 147.9% | |
| 2,535.1% | 1,587.2% | 3,056.5% | 2,806.8% | 2,143.4% | 1,771.2% | 3,107.5% | 1,591.4% | 4,009.8% | 5,980.1% | 7,191.1% | 4,385.6% | 3,928.6% | 911.2% | 4,524.1% | 6,490.9% | 2,036.5% | 3,574.7% | 2,467.9% | 1,677.1% | 366.0% | 3,020.2% | 218.8% | 188.3% | 267.3% | 441.4% | 373.4% | 251.8% | 624.6% | 384.1% | 542.4% | 513.6% | 200.6% | 272.8% | 530.7% | 814.0% | 202.7% | 198.1% | 529.3% | 917.2% | 301.8% | |
| -2,450.0% | -1,484.6% | -2,971.5% | -2,708.1% | -2,054.6% | -1,680.7% | -3,249.9% | -1,508.9% | -3,923.1% | -5,910.5% | -7,129.1% | -4,328.4% | -3,881.1% | -826.0% | -4,480.7% | -6,466.7% | -1,966.4% | -3,543.4% | -2,406.1% | -1,605.4% | -310.8% | -2,941.5% | -122.1% | -93.0% | -175.2% | -346.7% | -278.4% | -155.8% | -538.1% | -304.7% | -461.3% | -416.7% | -101.6% | -178.2% | -433.1% | -715.4% | -102.9% | -99.1% | -440.2% | -834.7% | -205.2% | |
| 42.8% | 30.9% | 80.7% | 3,400.0% | 2.2% | 23,674.5% | 27,866.1% | 742.2% | 29,129.2% | 40,915.2% | 52,576.5% | 16,902.8% | 8,819.8% | 296.8% | 244.0% | 383.8% | 73.7% | 1.2% | 0.7% | 0.7% | 0.0% | 0.3% | 0.0% | 1.1% | 12.8% | 14.5% | 18.2% | 11.8% | – | 20.8% | – | – | – | – | – | – | – | – | – | – | – | |
| 7,503.8% | -1,021.2% | 13,430.3% | -4,226.8% | 4,051.4% | -13,505.1% | -16,986.1% | -766.7% | 25,206.1% | -26,508.8% | 19,503.9% | -12,520.0% | -8,067.3% | -641.8% | -5,077.1% | -6,596.0% | -2,324.6% | 592.8% | -494.2% | -1,125.9% | -401.7% | -2,917.6% | -135.4% | -149.0% | -186.0% | -332.2% | -260.1% | -161.3% | -574.5% | -225.8% | -454.2% | -410.0% | -79.4% | -113.3% | -275.8% | -1,098.2% | -808.3% | -66.4% | -277.6% | 144.4% | -285.8% | |
| -20,710.0% | -1,847.9% | 1,023.0% | -1,017.6% | 1,030.7% | -838.7% | 27,826.1% | -1,609.6% | -58,255.7% | -202.3% | -2,449.2% | -499.2% | -456.7% | -94.2% | -472.3% | 1,436.4% | -52.0% | -639.2% | -4,408.5% | -38.3% | -46.0% | 123.0% | 23.0% | 70.0% | 18.0% | 12.0% | -75.6% | -6.4% | -3.9% | 2.9% | -1.1% | -0.9% | 0.9% | 0.3% | – | – | – | -79.9% | – | – | – | |
| 7,999.7% | -669.7% | 13,004.7% | -3,058.0% | 3,093.1% | -12,642.2% | -16,946.1% | -695.5% | 25,274.6% | -26,287.7% | 21,960.9% | -12,012.8% | -7,606.0% | -538.7% | -5,059.6% | -6,587.9% | -2,269.0% | 1,224.1% | -483.3% | -1,085.7% | -355.3% | -3,019.8% | -135.3% | -148.5% | -202.4% | -331.8% | -183.2% | -162.1% | -570.6% | -228.7% | -453.0% | -409.1% | -80.3% | -114.1% | -275.6% | -1,101.8% | -809.0% | 12.9% | -279.0% | 138.6% | -246.6% | |
| -2,221.5% | -1,375.6% | -2,755.7% | -2,501.6% | -1,875.2% | -1,529.5% | -2,806.4% | -1,366.8% | -3,618.2% | -5,538.6% | -6,707.8% | -4,028.0% | -3,530.4% | -653.6% | -4,053.0% | -5,917.2% | -1,835.1% | -3,341.0% | -2,308.5% | -1,080.5% | -392.7% | -2,897.7% | -132.0% | -144.9% | -179.5% | -323.2% | -253.0% | -156.1% | -560.4% | -217.4% | -442.0% | -399.9% | -75.7% | -108.1% | -264.9% | -172.5% | -803.4% | -63.6% | -266.7% | 161.9% | -280.1% |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.